Markets › India › NSE › ZYDUSLIFE

Zydus Lifesciences Ltd

NSE:ZYDUSLIFEHealthcareNSE:CNX100NSE:CNX200

₹1,113.90−0.81%At closeAt close · Mon 19 Oct · ≈ AED 42.98 · Market cap $11.78B · Next earnings Sat 14 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	65.7%	62.4%	62.5%	67.3%	71.9%	51.7%	—	—
Operating margin	36.2%	33.9%	33.4%	38.9%	41.3%	21.3%	21.3%	+0.0 pts
Net margin	14.8%	29.7%	11.4%	19.7%	19.5%	18.6%	18.6%	+0.0 pts
EBITDA margin	23.7%	21.0%	20.5%	26.9%	29.4%	31.5%	—	—
Return on equity	16.4%	26.4%	11.2%	19.5%	18.9%	18.6%	17.0%	−1.6 pts
Return on assets	8.9%	16.1%	7.6%	13.2%	12.2%	9.6%	9.6%	+0.0 pts
Return on capital employed	32.5%	25.7%	28.5%	31.7%	34.1%	15.8%	—	—
Debt / equity	0.4×	0.2×	0.1×	0.0×	0.1×	0.5×	0.4×	−8.4%
Debt / assets	19.3%	15.2%	4.6%	2.7%	8.6%	23.8%	—	—
Interest coverage	31.8×	42.8×	44.3×	154.4×	96.7×	13.2×	—	—
Current ratio	1.1×	1.5×	1.8×	2.1×	1.9×	1.3×	1.3×	+0.0%
Quick ratio	0.7×	1.1×	1.2×	1.5×	1.4×	0.9×	—	—
Cash ratio	0.1×	0.1×	0.1×	0.1×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	0.6×	0.5×	0.7×	0.7×	0.6×	0.5×	—	—
Inventory turnover	1.5×	1.5×	1.9×	1.9×	1.7×	2.3×	—	—
Receivables turnover	4.2×	4.3×	3.7×	3.6×	5.1×	5.0×	—	—
Dividend payout	0.1%	8.3%	13.6%	16.1%	6.7%	22.0%	—	—